Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by robertshawon Jul 13, 2019 5:40pm
56 Views
Post# 29917347

RE:RE:50 cent PP VS 35 cents

RE:RE:50 cent PP VS 35 cents
skier59 wrote: Geez can you just let me sign-out for the Summer without questioning my numbers.

You're wrong. 13 million shares and 13 million warrants that will become shares. That makes 26 million share difference. That's assuming the 15% over-allotment option is not exercised. If it is these will be the numbers;

15 million x 1.15 = 17.25 million/.35=50 million shares + 50 million warrants = 100 million shares
15 million x 1.15=17.25 million/.50 = 35 million shares = 35 million warrants = 70 million shares.

So the difference between 35 and 50 cents PP will be a net result of an additional 30 million shares PLUS the Brokerage warrants.

So if subscribe fully the difference between a 35 and a 50 cent PP will add an additional 30/180 f/d o/s shares current = 16.7% .....and that is HUGE !!!!!!!

Overall this PP can dilute us by 100 million/180 million or more simply put it will dilute us by 55%........

That is totally BullSh!t.......

.....and that my friends are the real facts.

We don't deserve this abuse, at this point of the game !


baystock1 wrote: Assuming the full $15 million is raised, the difference between 35 cents and 50 cents PP is an additional 13 million shares. This works out to an additional 7% share dilution, which is not that significant as compared to the importance of raising the money so as to be able to proceed with phase 2. This progress in the business is needed by end of year in order to raise an additonal $10 million from the 54c warrants that expire on March 3, 2020 which is only 7 months from now. I think all this hand wringing about the PP price is a tempest in a teapot. All us retail shareholders can really do is to protect our stake in the company from this dilution by buying the violent dip as stated by Macer, or even better to buy into the PP and actually put much needed funds into the hands of the company. If the PP is fully subscribed and warrants exercised, the next PP can be over $1.




Well said, Skier. Some stupid shareholders like Stockholm syndrome patient Kristina, just so addicted to tough abuse without realizing it is a kind of psychopathy ,this kind of person better seek out some mental treatment... We long suffered shareholders really don't deserve this kind of abuse.
Bullboard Posts